DR. ROBERT A. MARCINIAK, M.D.
Osteopathic Medicine at Wurzbach Rd, San Antonio, TX
License number
Texas L3005
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
7979 Wurzbach Rd, San Antonio, TX 78229
Phone
(210) 450-1000
(210) 450-1150 (Fax)
(210) 257-1400
(210) 257-1428 (Fax)
(210) 450-1150 (Fax)
(210) 257-1400
(210) 257-1428 (Fax)
Organization information
See more information about ROBERT A. MARCINIAK at bizstanding.comCancer Therapy & Research Center - Robert A Marciniak MD
7979 Wurzbach Rd #600, San Antonio, TX 78229
Categories:
Oncology Physicians & Surgeons, Physicians & Surgeons
Phone:
(210) 450-1000 (Phone)
University Of TX HSC San Anton - Robert A Marciniak MD
7703 Floyd Curl Dr, San Antonio, TX 78229
Categories:
Oncology Physicians & Surgeons, Urology Physicians & Surgeons
Phone:
(210) 567-7000 (Phone)
Professional information
Dr. Robert A Marciniak, San Antonio TX - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
Cancer Therapy and Research Center
7979 Wurzbach Rd, San Antonio 78229
(210) 450-1000 (Phone)
7979 Wurzbach Rd, San Antonio 78229
(210) 450-1000 (Phone)
Certifications:
Internal Medicine, 2009, Medical Oncology, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Cancer Therapy and Research Center
7979 Wurzbach Rd, San Antonio 78229
CHRISTUS Santa Rosa Hospital - City Center
333 North Santa Rosa St, San Antonio 78207
Methodist Hospital
7700 Floyd Curl Dr, San Antonio 78229
St. Lukes Baptist Hospital
7930 Floyd Curl Dr, San Antonio 78229
7979 Wurzbach Rd, San Antonio 78229
CHRISTUS Santa Rosa Hospital - City Center
333 North Santa Rosa St, San Antonio 78207
Methodist Hospital
7700 Floyd Curl Dr, San Antonio 78229
St. Lukes Baptist Hospital
7930 Floyd Curl Dr, San Antonio 78229
Education:
Medical School
Harvard Medical School
Mass Gen Hospital
Harvard Medical School
Mass Gen Hospital
Robert Anthony Marciniak, San Antonio TX
Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology, Emergency Medicine, Family Medicine, Neonatal-Perinatal Medicine
Work:
South Texas Veterans Health Services
7400 Merton Minter St, San Antonio, TX 78229
7400 Merton Minter St, San Antonio, TX 78229
Education:
Harvard University(1992)
Robert A Marciniak, San Antonio TX
Specialties:
Oncologist
Address:
7703 Floyd Curl Dr, San Antonio, TX 78229
7979 Wurzbach Rd, San Antonio, TX 78229
7979 Wurzbach Rd, San Antonio, TX 78229
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Multifunctional Core For Molecular Imaging And Targeted Delivery Of Macromolecules And Drugs
US Patent:
2007012, Jun 7, 2007
Filed:
Jul 27, 2006
Appl. No.:
11/460500
Inventors:
Zheng Wang - San Antonio TX, US
Irene Kazhdan - San Antonio TX, US
Jian Gao - Helotes TX, US
Zhiqiang Han - San Antonio MO, US
Robert Marciniak - San Antonio TX, US
Irene Kazhdan - San Antonio TX, US
Jian Gao - Helotes TX, US
Zhiqiang Han - San Antonio MO, US
Robert Marciniak - San Antonio TX, US
International Classification:
A61K 49/00, A61K 48/00, A61K 31/409, A61K 31/555
US Classification:
424009600, 514044000, 424009610, 514185000, 514410000
Abstract:
In the broadest sense an inventive conjugate includes a macrocyclic scaffold moiety incorporating at least one nitrogen atom. Through linkages to the ring, nitrogen atoms are bonded to at least one therapeutic species, or one cellular trafficking species, and preferably two or more types of trafficking species. The linkages between ring nitrogen atoms and agents are formed through N—C, N—S, N—O or N—N bonds. It is appreciated that more than one agent or agent species are coupled to a ring nitrogen atom through the inclusion of a branched carbon atom or secondary amine nitrogen within the intermediate between the agent and ring nitrogen atom. A disulfide bond intermediate between an agent and a linkage to the ring nitrogen is preferred in instances where intracellular release of the agent or trafficking species is desired. An optional metal ion is coordinated by the scaffolding moiety.
Compositions And Methods For Modulation Of Pdx-1
US Patent:
2009016, Jun 25, 2009
Filed:
Feb 14, 2008
Appl. No.:
12/031139
Inventors:
Irene Kazhdan - San Antonio TX, US
Zhiqiang Han - Fenton MO, US
Zheng Jim Wang - San Antonio TX, US
Ting-Tung Chang - San Antonio TX, US
Robert A. Marciniak - San Antonio TX, US
Zhiqiang Han - Fenton MO, US
Zheng Jim Wang - San Antonio TX, US
Ting-Tung Chang - San Antonio TX, US
Robert A. Marciniak - San Antonio TX, US
Assignee:
Ontherex LLC - San Antonio TX
International Classification:
A61K 31/7088, C12N 5/06, C12N 15/00
US Classification:
514 44, 435375, 4353201
Abstract:
Methods and compositions for inhibiting PDX-1 are provided according to the present invention. An anti-PDX-1 agent included in inventive methods and compositions includes an antibody, an aptamer, an antisense oligonucleotide, a ribozyme and/or an inhibitory compound. Methods of inhibiting PDX-1 expression in a tumor cell are provided by the present invention which include contacting a tumor cell with an effective amount of an anti-PDX- agent highly or completely complementary to a specified region of an RNA molecule encoding PDX-1. Such an agent specifically hybridizes with the RNA molecule encoding PDX-1 and inhibits the expression of a PDX-1 gene in the tumor cell. Compositions including anti-PDX-1 siRNA and/or shRNA are described. Recombinant expression constructs encoding anti-PDX-1 siRNA or shRNA according to the present invention are described.